Events
Next events
Jul 19, 2018
Bioxodes will present up-to-date preclinical data during the annual ISTH SSC meeting on Thursday 19 July 2018 in Dublin.
Poster presentation:
Abstract presentation number: PB503 - "Ir-CPI: an original inhibitor of thrombosis and thrombosis-associated with cancer"
Poster Session #2, Liffey B
19.07.2018
Oral presentation:
"Ir-CPI a New Potent Inhibitor of Thrombosis and Thrombosis Associated with Cancer"
SSC Session, Wicklow Hall 2
19.07.2018, 10:30 - 11:00
Link: http://www.ssc2018.org/
Dublin, Ireland
Jul 19, 2018
Bioxodes has been invited based on its high-scoring abstract to give an oral presentation in the SCC Subcommittee on Hemostasis and Malignancy session
Oral presentation:
"Ir-CPI a New Potent Inhibitor of Thrombosis and Thrombosis Associated with Cancer"
SSC Session, Wicklow Hall 2
19.07.2018, 08:00 – 8:15
Link: http://www.ssc2018.org/
Dublin, Ireland
Previous events
Jul 10, 2017
Abstract Title: "Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment"
Link: http://www.isth2017.org/
Berlin, Germany
May 1, 2016
Bioxodes to participate at the ISTH SCC 2016 annual congress.
Montpellier, France
Jun 1, 2015
Abstract titles :
“Efficacy of a novel contact pathway inhibitor, Ir-CPI, in an extracorporeal membrane oxygenator model”
“Antithrombotic effects of Ir-CPI in an arterio-venous shunt model in the rabbit”
“Evaluation of the effects of a novel contact pathway inhibitor, Ir-CPI, on in vitro platelet function and coagulation”
Toronto, Canada